Corient Private Wealth LLC Sells 6,175 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Corient Private Wealth LLC lessened its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 19.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,769 shares of the health services provider’s stock after selling 6,175 shares during the period. Corient Private Wealth LLC’s holdings in Teladoc Health were worth $234,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares during the period. Whipplewood Advisors LLC bought a new position in Teladoc Health in the 4th quarter worth about $29,000. Lindbrook Capital LLC increased its position in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after acquiring an additional 1,612 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Teladoc Health by 22.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock valued at $73,000 after acquiring an additional 1,439 shares in the last quarter. Finally, KBC Group NV boosted its holdings in shares of Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares during the period. Institutional investors own 76.82% of the company’s stock.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Stock Down 1.4 %

Teladoc Health stock opened at $7.97 on Tuesday. The business has a fifty day moving average price of $10.32 and a 200-day moving average price of $9.81. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $15.27. The stock has a market capitalization of $1.38 billion, a price-to-earnings ratio of -1.38 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Equities research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Bank of America raised their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a report on Wednesday, February 12th. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $11.26.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.